UTI AMC Q2FY23 PAT up 0.89% at Rs200.5 crore as higher deferred tax liability subdues profit growth

25 Oct 2022 , 08:59 PM

UTI AMC reported 14.83% growth in total revenues for the September 2022 quarter on consolidated basis at Rs439.92cr.

Revenue growth was 43.77% in sequential terms. The top line got a boost from the net gains on fair value changes in the quarter on the back of rising asset values.

However, the basic income from asset management fees remained almost constant a midst falling fund management fees in percentage terms.

Its overall AUM touched Rs14.45 trillion with core AUM of Rs2.34 trillion. NPA AUM market share is 27.2%.

Consolidated Profit after tax (PAT) for September 2022 quarter was up 0.89% at Rs200.50cr and it was 112.37% higher on sequential basis.

The profit on sequential basis got a boost from the net change in fair value in the latest quarter. EBITDA grew at 10% while the core EBITDA grew at 5% yoy.

It had total live folios of 1.21 crore and SIP gross sales of Rs1,589 crore in the quarter. ETF and Index AUM stands at Rs75,454 crore. Net profit margins at 45.6% in Q2FY23 are lower compared to 51.9% in Q2FY22 but better than 30.9% in Q2FY23.

Financial highlights for Sep-22 compared yoy and sequentially

	UTI AMC
Rs in Crore	Sep-22	Sep-21	YOY	Jun-22	QOQ
Total Income (Rs cr)	₹ 439.92	₹ 383.12	14.83%	₹ 305.99	43.77%
Net Profit (Rs cr)	₹ 200.50	₹ 198.74	0.89%	₹ 94.41	112.37%
Diluted EPS (Rs)	₹ 15.79	₹ 15.62		₹ 7.43
Net Margins	45.58%	51.87%		30.85%